<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Agios Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $542,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jacqualyn Fouse, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    ProQR Therapeutics N.V.

    ProQR Therapeutics N.V.

    We are ProQR, a company on a mission to create new medicines for patients in need....

    We are ProQR, a company on a mission to create ...

    Filing Type:    PU
    Verrica Pharmaceuticals Inc.

    Verrica Pharmaceuticals Inc.

    Verrica Pharmaceuticals Inc. is an innovative clinical-stage medical dermatology c...

    Verrica Pharmaceuticals Inc. is an innovative c...

    Filing Type:    PU
    Geron Corporation

    Geron Corporation

    Geron is a late-stage clinical biopharmaceutical company focused on the developmen...

    Geron is a late-stage clinical biopharmaceutica...

    Filing Type:    PU
    ArQule, Inc.

    ArQule, Inc.

    ArQule is a biopharmaceutical company engaged in the research and development of t...

    ArQule is a biopharmaceutical company engaged i...

    Filing Type:    PU
    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical c...

    Corbus Pharmaceuticals Holdings, Inc. is a Phas...

    Filing Type:    PU
    BioLineRx Ltd.

    BioLineRx Ltd.

    BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The C...

    BioLineRx is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Allogene Therapeutics, Inc.

    Allogene Therapeutics, Inc.

    Allogene Therapeutics is a clinical stage biotechnology company pioneering the dev...

    Allogene Therapeutics is a clinical stage biote...

    Filing Type:    PU
    CytomX Therapeutics, Inc.

    CytomX Therapeutics, Inc.

    CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...

    CytomX Therapeutics develops Probody™ therape...

    Filing Type:    PU
    Surface Oncology, Inc.

    Surface Oncology, Inc.

    Surface Oncology is an immuno-oncology company on a mission to break through and d...

    Surface Oncology is an immuno-oncology company ...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.